These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15330810)

  • 1. Differentiation and proliferation related proteins in the epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.
    McCluggage WG
    Histopathology; 2004 Sep; 45(3):298-9. PubMed ID: 15330810
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.
    Piek JM; Verheijen RH; Menko FH; Jongsma AP; Weegenaar J; Gille JJ; Pals G; Kenemans P; van Diest PJ
    Histopathology; 2003 Jul; 43(1):26-32. PubMed ID: 12823709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
    Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
    Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cell cycle regulatory proteins in ovaries prophylactically removed from Jewish Ashkenazi BRCA1 and BRCA2 mutation carriers: correlation with histopathology.
    Kerner R; Sabo E; Gershoni-Baruch R; Beck D; Ben-Izhak O
    Gynecol Oncol; 2005 Nov; 99(2):367-75. PubMed ID: 16051332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
    Piek JM; van Diest PJ; Zweemer RP; Jansen JW; Poort-Keesom RJ; Menko FH; Gille JJ; Jongsma AP; Pals G; Kenemans P; Verheijen RH
    J Pathol; 2001 Nov; 195(4):451-6. PubMed ID: 11745677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epithelial ovarian cancer dysplasia: At last a "precancerous" lesion of the ovary!].
    Sabourin JC
    Ann Pathol; 2011 Feb; 31(1):2. PubMed ID: 21349381
    [No Abstract]   [Full Text] [Related]  

  • 7. The Brenner tumor and the Walthard cell nest. An electron microscopic study.
    Roth LM
    Lab Invest; 1974 Jul; 31(1):15-23. PubMed ID: 4367229
    [No Abstract]   [Full Text] [Related]  

  • 8. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of BTAK expression in primary ovarian surface epithelial cells of prophylactic ovaries.
    Zhang Z; Singh M; Davidson S; Rosen DG; Yang G; Liu J
    Mod Pathol; 2007 Oct; 20(10):1078-84. PubMed ID: 17673924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.
    Clark-Knowles KV; Garson K; Jonkers J; Vanderhyden BC
    Exp Cell Res; 2007 Jan; 313(1):133-45. PubMed ID: 17070800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies.
    He QY; Zhou Y; Wong E; Ehlen TG; Auersperg N; Chiu JF; Wong AS
    Gynecol Oncol; 2005 Jul; 98(1):68-76. PubMed ID: 15913737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
    Hermsen BB; von Mensdorff-Pouilly S; Berkhof J; van Diest PJ; Gille JJ; Menko FH; Blankenstein MA; Kenemans P; Verheijen RH
    J Clin Oncol; 2007 Apr; 25(11):1383-9. PubMed ID: 17416858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma.
    Seidman JD; Wang BG
    Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral ovarian serous cystadenofibromas coexisting with an incidental unilateral Brenner tumor and Walthard cell rests in bilateral Fallopian tubes: an unusual case with diagnostic implications and histogenesis.
    Rekhi B; Vinarkar S; Shylasree ST
    Indian J Pathol Microbiol; 2014; 57(2):347-8. PubMed ID: 24943791
    [No Abstract]   [Full Text] [Related]  

  • 15. Extramedullary hematopoiesis and myeloid metaplasia of the ovaries and tubes in a patient with myelofibrosis: case report and concise review of the reported cases.
    Rabischong B; Larraín D; Charpy C; Déchelotte PJ; Mage G
    J Clin Oncol; 2010 Oct; 28(28):e511-2. PubMed ID: 20697095
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.
    Tone AA; Begley H; Sharma M; Murphy J; Rosen B; Brown TJ; Shaw PA
    Clin Cancer Res; 2008 Jul; 14(13):4067-78. PubMed ID: 18593983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.
    Piek JM; Kenemans P; Verheijen RH
    Am J Obstet Gynecol; 2004 Sep; 191(3):718-32. PubMed ID: 15467531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
    Salazar H; Godwin AK; Daly MB; Laub PB; Hogan WM; Rosenblum N; Boente MP; Lynch HT; Hamilton TC
    J Natl Cancer Inst; 1996 Dec; 88(24):1810-20. PubMed ID: 8961970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benign and precancerous changes in the ovarian surface epithelium].
    Rothacker D
    Pathologe; 1991 Sep; 12(5):266-9. PubMed ID: 1946233
    [No Abstract]   [Full Text] [Related]  

  • 20. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells.
    Shepherd TG; Thériault BL; Nachtigal MW
    Gene; 2008 May; 414(1-2):95-105. PubMed ID: 18372118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.